Concepedia

Margaret Gartland

MG

Statistics

Publications

12

Citations

746

H-Index

12

Active since

1999

Affiliations

GlaxoSmithKline (United States)(Current)

Georgetown University

Assistance Publique – Hôpitaux de Paris

Orlando Immunology Center

Icahn School of Medicine at Mount Sinai

Margaret Gartland is an author at GlaxoSmithKline (United States) specializing in molecular virology, antiretroviral therapy, and antiviral therapy.

ORCID

Publications per year

1999–2023

12

Publications

12

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Judith A. Aberg, Gilles Pialoux, Pedro Cahn et al. · New England Journal of Medicine · 2020 · 176 citations · Full text

, , +10

An infectious molecular clone of a Japanese genotype 1b hepatitis C virus

Michael R. Beard, Geoffrey Abell, Masao Honda et al. · Hepatology · 1999 · 143 citations

, , +14

Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

Max Lataillade, Jacob Lalezari, Judith A. Aberg et al. · The Lancet HIV · 2020 · 89 citations

, , +14

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

Edward P. Garvey, Brian A. Johns, Margaret Gartland et al. · Antimicrobial Agents and Chemotherapy · 2007 · 76 citations · Full text

, , +17

GSK983: A novel compound with broad-spectrum antiviral activity

Kevin Brown, Qin Zhang, Margaret Gartland et al. · Antiviral Research · 2009 · 69 citations

, , +13

1–5 of 12